Integrating pharmacogenetics, multi‐omics and machine learning in the novel therapeutic view of pulmonary hypertension
Abstract It is a complex disease with multiple pathogenesis that causes pulmonary hypertension (PH). In addition to the commonly used drugs for treating PH, pharmacogenomic therapies are facilitating the innovation of personalized medicine to treat PH. Meanwhile, gene therapy has been extensively st...
Saved in:
Main Authors: | Chenxi Li, Jipeng Xue, Dongchen Zhou, Xiaomeng Qi, Ting Chen, Zhoubin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2025-01-01
|
Series: | Interdisciplinary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/INMD.20240029 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New therapies in pulmonary arterial hypertension: Recent insights
by: Giulia Guglielmi, et al.
Published: (2025-03-01) -
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions
by: Ioan Teodor Dragoi, et al.
Published: (2024-12-01) -
Early Echocardiographic Findings of Pulmonary Hypertension-specific Therapy in Children
by: Akif KAVGACI, et al.
Published: (2023-12-01) -
Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results from a cohort in Brazil
by: Fabio Solano de Freitas Souza, et al.
Published: (2025-01-01) -
A novel dual fixation method for improving the reliable assessment of pulmonary vascular morphology in pulmonary hypertension rats
by: Yan Xu, et al.
Published: (2025-01-01)